Abstract
Erectile dysfunction (ED) is estimated to impact more than 150 million men this year worldwide. An understanding of the pathophysiology of ED both furthers the basic scientific knowledge of disease processes and provides a rational design of pharmacotherapy. At present, there are two major views regarding the pathophysiology of ED. In the first hypothesis, the oxygen tension-dependent changes in the penis during erection are proposed to impact corpus cavernosum structure by inducing various cytokines, vasoactive factors and growth factors at the two different oxygen tensions (flaccidity and erection) which, in turn, alter smooth muscle metabolism and connective tissue synthesis. Decreases in the corpus cavernosum smooth muscle/connective tissue ratio have been correlated with an increased likelihood of diffuse venous leak and a failure of the veno-occlusive mechanism in prospective patient studies. Evidence for such a hypothesis incorporates nocturnal penile tumescence and circadian changes in oxygenation as important in maintaining erectile health. The alternate hypothesis proposes that ED is the result of a metabolic imbalance between relaxatory and contractile processes within the trabecular smooth muscle such that contractile processes predominate. Based on this hypothesis, therapy can be accomplished via drugs which shift this balance towards vasodilatation, or by gene therapy approaches to supplement the deficient components favoring smooth muscle relaxation. Both of these hypotheses predict a management strategy for ED that impacts pharmacotherapeutics. In this review of the pathophysiology of ED, each hypothesis will be examined and a synthesis devised incorporating both views. The future of research in this area as well as pharmacotherapy in ED in terms of pathophysiology is discussed including the merits and drawbacks of prophylaxis and prevention of ED.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moreland, R. Pathophysiology of erectile dysfunction: the contributions of trabecular structure to function and the role of functional antagonism. Int J Impot Res 12 (Suppl 4), S39–S46 (2000). https://doi.org/10.1038/sj.ijir.3900576
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3900576
Keywords
This article is cited by
-
Cavernous smooth muscles: innovative potential therapies are promising for an unrevealed clinical diagnosis
International Urology and Nephrology (2020)
-
The correlation between high sensitivity C-reactive protein and erectile dysfunction patients with hypertension treated with vardenafil
International Journal of Impotence Research (2017)
-
Androgen depletion in humans leads to cavernous tissue reorganization and upregulation of Sirt1–eNOS axis
AGE (2013)
-
Erectile tissue molecular alterations with aging—differential activation of the p42/44 MAP Kinase pathway
AGE (2011)
-
Rationale for phosphodiesterase 5 inhibitor use post-radical prostatectomy: experimental and clinical review
International Journal of Impotence Research (2008)